Eline Van Vooren

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

ORCID iD: 0000-0002-8731-1199

Add to list
- PhD Thesis
Illuminating the many faces of RPE65: from recessive to dominant retinopathy

Eline Van Vooren (UGent)

(2026)
Add to list
- Conference Paper
- C3
- open access
In-depth phenotypic study of a Novel Autosomal Dominant RPE65-related Retinal Dystrophy

Filip Van Den Broeck (UGent) , Eline Van Vooren (UGent) , Manon Van Haute (UGent) , Marieke De Bruyne (UGent) , Stijn Van de Sompele (UGent) , Mattias Van Heetvelde (UGent) , Quinten Mahieu (UGent) , Sheetal Uppal, Eugenia Poliakov, T. Michael Redmond, et al.

(2025) INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. In Investigative Ophthalmology & Visual Science 66(8).
Add to list
- Conference Paper
- C3
Discovery, replication and characterization of a novel dominantRPE65-related retinopathy due to founder variant p.(E519K) expanding the therapeutic potential

Eline Van Vooren (UGent) , Filip Van Den Broeck (UGent) , Quinten Mahieu (UGent) , Eline Geens (UGent) , Mattias Van Heetvelde (UGent) , Marieke De Bruyne (UGent) , Stijn Van de Sompele (UGent) , Sheetal Uppal, Eugenia Poliakov, Claire-Marie Dhaenens, et al.

(2025) EUROPEAN JOURNAL OF HUMAN GENETICS. In European Journal of Human Genetics 33(Supplement 1). p.94-95
Add to list
- Miscellaneous
RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals

Eline Van Vooren (UGent) , Filip Van Den Broeck (UGent) , Quinten Mahieu (UGent) , Eline Geens (UGent) , Mattias Van Heetvelde (UGent) , Marieke De Bruyne (UGent) , Stijn Van de Sompele (UGent) , Sheetal Uppal, Eugenia Poliakov, Claire-Marie Dhaenens, et al.

(2025) Research Square.
Add to list
- Journal Article
- A1
- open access
Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G>A, p.(E519K)

Eline Van Vooren (UGent) , Filip Van Den Broeck (UGent) , Esperanza Daal (UGent) , Mehrnaz Ghazvini, Julie De Zaeytijd (UGent) , Bart Leroy (UGent) , Miriam Bauwens (UGent) and Elfride De Baere (UGent)

(2025) STEM CELL RESEARCH. 89.
Add to list
- Journal Article
- A1
- open access
RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals

Eline Van Vooren (UGent) , Filip Van Den Broeck (UGent) , Quinten Mahieu (UGent) , Eline Geens (UGent) , Mattias Van Heetvelde (UGent) , Marieke De Bruyne (UGent) , Stijn Van de Sompele (UGent) , Sheetal Uppal, Eugenia Poliakov, Claire-Marie Dhaenens, et al.

(2025) INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 66(12).
Add to list
- Conference Paper
- C3
A novel RPE65-related dominant retinopathy caused by founder variant c.1555G>A p.(Glu519Lys) enriched in Belgian patients with a recognizable pattern dystrophy spectrum

Eline Van Vooren (UGent) , Filip Van Den Broeck (UGent) , Eline Geens (UGent) , Marieke De Bruyne (UGent) , Stijn Van de Sompele (UGent) , Quinten Mahieu (UGent) , Sheetal Uppal, Eugenia Poliakov, Michael T. Redmond, Julie De Zaeytijd (UGent) , et al.

(2024) EUROPEAN JOURNAL OF HUMAN GENETICS. 32(Suppl. 2). p.1332-1332
Add to list
- Conference Paper
- C3
An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Eline Van Vooren (UGent) , Suzanne Kohl, Carlo Rivolta, Bart Leroy (UGent) , Miriam Bauwens (UGent) and Elfride De Baere (UGent)

(2023) Research Day 2023, Abstracts.
Add to list
- Conference Paper
- C3
- open access
An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Eline Van Vooren (UGent) , Suzanne Kohl, Carlo Rivolta, Bart Leroy (UGent) , Miriam Bauwens (UGent) and Elfride De Baere (UGent)

(2023) Belgian Society for Human Genetics (BeSHG) Annual Meeting 2023 : To DNA and beyond, Abstracts.
Add to list
- Conference Paper
- C3
- open access
An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Eline Van Vooren (UGent) , Suzanne Kohl, Bart Leroy (UGent) , Miriam Bauwens (UGent) and Elfride De Baere (UGent)

(2022) RARE-MED Symposium 2022, Abstracts. p.27-27

Academic Bibliography

Eline Van Vooren

Illuminating the many faces of RPE65: from recessive to dominant retinopathy

In-depth phenotypic study of a Novel Autosomal Dominant RPE65-related Retinal Dystrophy

Discovery, replication and characterization of a novel dominantRPE65-related retinopathy due to founder variant p.(E519K) expanding the therapeutic potential

RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals

Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G>A, p.(E519K)

RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals

A novel RPE65-related dominant retinopathy caused by founder variant c.1555G>A p.(Glu519Lys) enriched in Belgian patients with a recognizable pattern dystrophy spectrum

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Contents

Support

Contact

Illuminating the many faces of RPE65: from recessive to dominant retinopathy

In-depth phenotypic study of a Novel Autosomal Dominant RPE65-related Retinal Dystrophy

Discovery, replication and characterization of a novel dominantRPE65-related retinopathy due to founder variant p.(E519K) expanding the therapeutic potential

RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals

Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G&gt;A, p.(E519K)

RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals

A novel RPE65-related dominant retinopathy caused by founder variant c.1555G>A p.(Glu519Lys) enriched in Belgian patients with a recognizable pattern dystrophy spectrum

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

An in vitro enzymatic assay to elucidate the VUS problem in RPE65, a target for retinal gene therapy

Generation and characterization of three human induced pluripotent stem cell lines (UGENTi005, UGENTi006 and UGENTi007) from patients with autosomal dominant adult-onset maculopathy due to RPE65 variant c.1555G>A, p.(E519K)